论文部分内容阅读
目的:观察布托啡诺治疗剖宫产术中寒战对新生儿的影响。方法:选择剖宫产术中寒战产妇60例,随机数字法分为两组,每组30例,行双盲试验。在胎儿娩出前静脉注射:A组给予布托啡诺0.5 mg稀释至5 ml,B组给予等容量生理盐水,记录新生儿1、5 min的Apgar评分,产后2、12 h神经和适应能力评分(NACS)及检测脐动、静脉血气分析(pH、PCO2、PO2、HCO-3)。结果:两组新生儿1、5 min的Apgar评分,产后2、12 h的NACS及脐动、静脉血气分析(pH、PCO2、PO2、HCO-3)比较,差异均无统计学意义。结论:布托啡诺0.5 mg治疗剖宫产术中寒战对新生儿无明显抑制。
OBJECTIVE: To observe the effect of butorphanol in the treatment of newborn during cesarean section. Methods: Sixty cases of shivering mothers during cesarean section were randomly divided into two groups (n = 30 in each group). Intravenous injection of fetus before delivery: group A were given butorphanol 0.5 mg diluted to 5 ml, group B was given the same volume of normal saline, neonatal 1,5 min Apgar score, 2 h postpartum nerve and adaptive capacity score (NACS) and detection of umbilical arterial and venous blood gas analysis (pH, PCO2, PO2, HCO-3). Results: There was no significant difference in Apgar score at 1, 5 min, NACS and umbilical arterial and venous blood gas analysis (pH, PCO2, PO2, HCO-3) at 2 and 12 h postpartum in both groups. CONCLUSION: Butorphanol 0.5 mg in childern cesarean section has no significant effect on the newborn.